Further, PCK1 is involved in metabolic changes in cancer cells and is considered a potential treatment target in hepatocellular carcinoma [4, 6, 7] and clear cell renal cell carcinoma (ccRCC) [8]. The gene discussed is PCK1; the disease is nonpapillary renal cell carcinoma.